Tezspire Approved for Self-Administration in the U.S. With a New Pre-filled Pen

Now Offers Patients the Choice of Administration at Home or in a Doctor ' s Office THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news